Brief: Axonics Receives FDA Approval For Fourth-Generation Rechargeable Sacral Neuromodulation System
31/01/2023 13:42
Jan 31 (Reuters) - Axonics Inc AXNX.O :
* AXONICS RECEIVES FDA APPROVAL FOR FOURTH-GENERATION
RECHARGEABLE
SACRAL NEUROMODULATION SYSTEM
* AXONICS RECEIVES FDA APPROVAL FOR FOURTH-GENERATION
RECHARGEABLE
SACRAL NEUROMODULATION SYSTEM
Source text for Eikon: ID:nBw1GJccZa
Further company coverage: AXNX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Axonics
See all newsBrief: Boston Scientific Closes Acquisition Of Axonics, Inc.
Axonics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Axonics Q3 Basic EPS USD 0
Axonics Inc expected to post earnings of 13 cents a share - Earnings Preview
Axonics Inc expected to post earnings of 13 cents a share - Earnings Preview